- Home
- TRML vs PSTX Comparison
TRML vs PSTX Comparison
Compare TRML & PSTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRML
- PSTX
- Stock Information
- Founded
- TRML 2021
- PSTX 2014
- Country
- TRML United States
- PSTX United States
- Employees
- TRML N/A
- PSTX N/A
- Industry
- TRML Biotechnology: Pharmaceutical Preparations
- PSTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TRML Health Care
- PSTX Health Care
- Exchange
- TRML Nasdaq
- PSTX Nasdaq
- Market Cap
- TRML 419.1M
- PSTX 360.4M
- IPO Year
- TRML N/A
- PSTX 2020
- Fundamental
- Price
- TRML $23.01
- PSTX $2.73
- Analyst Decision
- TRML Strong Buy
- PSTX Strong Buy
- Analyst Count
- TRML 3
- PSTX 2
- Target Price
- TRML $65.00
- PSTX $15.00
- AVG Volume (30 Days)
- TRML 187.7K
- PSTX 557.9K
- Earning Date
- TRML 11-07-2024
- PSTX 11-07-2024
- Dividend Yield
- TRML N/A
- PSTX N/A
- EPS Growth
- TRML N/A
- PSTX N/A
- EPS
- TRML N/A
- PSTX N/A
- Revenue
- TRML N/A
- PSTX $150,858,000.00
- Revenue This Year
- TRML N/A
- PSTX $64.38
- Revenue Next Year
- TRML N/A
- PSTX N/A
- P/E Ratio
- TRML N/A
- PSTX N/A
- Revenue Growth
- TRML N/A
- PSTX 203.18
- 52 Week Low
- TRML $12.12
- PSTX $1.87
- 52 Week High
- TRML $48.31
- PSTX $4.27
- Technical
- Relative Strength Index (RSI)
- TRML 37.25
- PSTX 47.45
- Support Level
- TRML $25.58
- PSTX $2.63
- Resistance Level
- TRML $27.51
- PSTX $2.82
- Average True Range (ATR)
- TRML 1.81
- PSTX 0.33
- MACD
- TRML -0.61
- PSTX -0.04
- Stochastic Oscillator
- TRML 10.76
- PSTX 18.38
About TRML Tourmaline Bio Inc.
Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.
About PSTX Poseida Therapeutics Inc.
Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with a high unmet medical need. It has built a pipeline of autologous and allogeneic chimeric antigen receptor T cell, or CAR-T, product candidates, initially focused on the treatment of hematological malignancies and solid tumours.